CS23546
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CS23546, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CS23546 in Subjects With Advanced Tumors [Phase 1]